These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19395969)

  • 41. [Rush desensitization to respiratory allergens].
    Bousquet J; Guèrin B; Michel FB
    Presse Med; 1984 Dec; 13(44):2679-83. PubMed ID: 6240031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation.
    Alam M; Yoo SS; Wrone DA; White LE; Kim JY
    J Am Acad Dermatol; 2006 Aug; 55(2):272-5. PubMed ID: 16844511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data.
    Larenas-Linnemann DE; Epstein T; Ponda P; Bernstein D; Williams P; Creticos P
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):505-506.e2. PubMed ID: 32693206
    [No Abstract]   [Full Text] [Related]  

  • 44. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
    Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
    [No Abstract]   [Full Text] [Related]  

  • 45. Advances in upper airway diseases and allergen immunotherapy in 2011.
    Hsu J; Saltoun CA; Avila PC
    J Allergy Clin Immunol; 2012 Mar; 129(3):646-52. PubMed ID: 22305680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency of mold and pollen mixing in allergen immunotherapy prescriptions within a large health care system, 1990-2010.
    Gada S; Haymore B; McCoy L; Kosisky S; Nelson M
    J Allergy Clin Immunol; 2012 Apr; 129(4):1151-3. PubMed ID: 22154380
    [No Abstract]   [Full Text] [Related]  

  • 47. A review of allergen-specific immunotherapy in human and veterinary medicine.
    Loewenstein C; Mueller RS
    Vet Dermatol; 2009 Apr; 20(2):84-98. PubMed ID: 19320877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Office-based oral immunotherapy for food allergy is safe and effective.
    Wasserman RL; Sugerman RW; Mireku-Akomeah N; Mansfield L; Baker JW
    J Allergy Clin Immunol; 2011 Jan; 127(1):290-1; author reply 291-2. PubMed ID: 21040956
    [No Abstract]   [Full Text] [Related]  

  • 49. Decontamination technology: the missing element.
    Rahe H
    Int J Pharm Compd; 2013; 17(3):193-9. PubMed ID: 24046934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Specific hyposensitization].
    Bartsch P
    Rev Med Liege; 1984 May; 39(9):349-53. PubMed ID: 6729306
    [No Abstract]   [Full Text] [Related]  

  • 51. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 52. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut].
    May S; Kaul S; Schröder C; Vieths S
    Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Allergen immunotherapy for prevention and treatment of respiratory allergy in childhood].
    ; Saranz RJ; Lozano A; Cáceres ME; Arnolt RG; Máspero JF; Bozzola CM; Neffen HE; Croce VH; Gualtier O; Procopio N
    Arch Argent Pediatr; 2010 Jun; 108(3):258-65. PubMed ID: 20544144
    [No Abstract]   [Full Text] [Related]  

  • 54. Is immunotherapy with fungal vaccines effective?
    Di Bona D; Albanesi M; Macchia L
    Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):646-653. PubMed ID: 31403481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Specific desensitization].
    Vervloet D; Charpin J
    Rev Prat; 1982 Apr; 32(23):1577-8 passim. PubMed ID: 7089464
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinico-immunologic course during immunotherapy for pneumoallergens].
    López de Armentia SL
    Allergol Immunopathol (Madr); 1996; 24 Suppl 1():80-4. PubMed ID: 8815726
    [No Abstract]   [Full Text] [Related]  

  • 58. [Respiratory allergy in childhood. Specific immunotherapy].
    Zannino L
    Minerva Pediatr; 1981 Aug; 33(15):759-72. PubMed ID: 7027016
    [No Abstract]   [Full Text] [Related]  

  • 59. [Practice patterns in Mexican allergologists about specific immunotherapy with allergens].
    Larenas Linnemann D; Guidos Fogelbach GA; Arias Cruz A
    Rev Alerg Mex; 2008; 55(2):53-61. PubMed ID: 19058482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy preparation guidelines, rules, and regulation.
    Esch RE; Plunkett GA
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):406-13. PubMed ID: 23722699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.